FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226021903> ?p ?o ?g. }

• W4226021903 abstract "Prospective cohort studies are challenging to deliver, with one of the main difficulties lying in retention of participants. The need to socially distance during the COVID-19 pandemic has added to this challenge. The pre-COVID-19 adaptation of the European Quality (EQUAL) study in the UK to a remote form of follow-up for efficiency provides lessons for those who are considering changing their study design.The EQUAL study is an international prospective cohort study of patients ≥65 years of age with advanced chronic kidney disease. Initially, patients were invited to complete a questionnaire (SF-36, Dialysis Symptom Index and Renal Treatment Satisfaction Questionnaire) at research clinics every 3-6 months, known as traditional follow-up (TFU). In 2018, all living patients were invited to switch to efficient follow-up (EFU), which used an abbreviated questionnaire consisting of SF-12 and Dialysis Symptom Index. These were administered centrally by post. Response rates were calculated using returned questionnaires as a proportion of surviving invitees, and error rates presented as the average percentage of unanswered questions or unclear answers, of total questions in returned questionnaires. Response and error rates were calculated 6-monthly in TFU to allow comparisons with EFU.Of the 504 patients initially recruited, 236 were still alive at the time of conversion to EFU; 111 of these (47%) consented to the change in follow-up. In those who consented, median TFU was 34 months, ranging from 0 to 42 months. Their response rates fell steadily from 88% (98/111) at month 0 of TFU, to 20% (3/15) at month 42. The response rate for the first EFU questionnaire was 60% (59/99) of those alive from TFU. With this improvement in response rates, the first EFU also lowered errors to baseline levels seen in early follow-up, after having almost trebled throughout traditional follow-up.Overall, this study demonstrates that administration of shorter follow-up questionnaires by post rather than in person does not negatively impact patient response or error rates. These results may be reassuring for researchers who are trying to limit face-to-face contact with patients during the COVID-19 pandemic." @default.
• W4226021903 created "2022-05-05" @default.
• W4226021903 creator A5005373304 @default.
• W4226021903 creator A5013933989 @default.
• W4226021903 creator A5017419996 @default.
• W4226021903 creator A5021631280 @default.
• W4226021903 creator A5022085293 @default.
• W4226021903 creator A5024355094 @default.
• W4226021903 creator A5033368647 @default.
• W4226021903 creator A5039307129 @default.
• W4226021903 creator A5040457003 @default.
• W4226021903 creator A5045807220 @default.
• W4226021903 creator A5046569845 @default.
• W4226021903 creator A5050155633 @default.
• W4226021903 creator A5055190032 @default.
• W4226021903 creator A5068253838 @default.
• W4226021903 creator A5072200320 @default.
• W4226021903 creator A5086569880 @default.
• W4226021903 creator A5088349178 @default.
• W4226021903 date "2022-02-11" @default.
• W4226021903 modified "2023-10-09" @default.
• W4226021903 title "Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK" @default.
• W4226021903 cites W14889875 @default.
• W4226021903 cites W1526521610 @default.
• W4226021903 cites W1566155680 @default.
• W4226021903 cites W1964150654 @default.
• W4226021903 cites W1988602110 @default.
• W4226021903 cites W2000445173 @default.
• W4226021903 cites W2009899617 @default.
• W4226021903 cites W2011590376 @default.
• W4226021903 cites W2011769683 @default.
• W4226021903 cites W2037377025 @default.
• W4226021903 cites W2073742622 @default.
• W4226021903 cites W2079212417 @default.
• W4226021903 cites W2095448457 @default.
• W4226021903 cites W2124486693 @default.
• W4226021903 cites W2124898212 @default.
• W4226021903 cites W2127151178 @default.
• W4226021903 cites W2131060308 @default.
• W4226021903 cites W2144042764 @default.
• W4226021903 cites W2146951082 @default.
• W4226021903 cites W2147323872 @default.
• W4226021903 cites W2169612163 @default.
• W4226021903 cites W2172151487 @default.
• W4226021903 cites W2475102738 @default.
• W4226021903 cites W2766029560 @default.
• W4226021903 cites W2776212325 @default.
• W4226021903 cites W2782661994 @default.
• W4226021903 cites W2797827880 @default.
• W4226021903 cites W2807834281 @default.
• W4226021903 cites W2809216819 @default.
• W4226021903 cites W2889923260 @default.
• W4226021903 cites W2903570830 @default.
• W4226021903 cites W3006248243 @default.
• W4226021903 cites W3012797216 @default.
• W4226021903 cites W3014888129 @default.
• W4226021903 cites W4249546181 @default.
• W4226021903 cites W4292806894 @default.
• W4226021903 doi "https://doi.org/10.1186/s12874-021-01453-0" @default.
• W4226021903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35148682" @default.
• W4226021903 hasPublicationYear "2022" @default.
• W4226021903 type Work @default.
• W4226021903 citedByCount "1" @default.
• W4226021903 countsByYear W42260219032023 @default.
• W4226021903 crossrefType "journal-article" @default.
• W4226021903 hasAuthorship W4226021903A5005373304 @default.
• W4226021903 hasAuthorship W4226021903A5013933989 @default.
• W4226021903 hasAuthorship W4226021903A5017419996 @default.
• W4226021903 hasAuthorship W4226021903A5021631280 @default.
• W4226021903 hasAuthorship W4226021903A5022085293 @default.
• W4226021903 hasAuthorship W4226021903A5024355094 @default.
• W4226021903 hasAuthorship W4226021903A5033368647 @default.
• W4226021903 hasAuthorship W4226021903A5039307129 @default.
• W4226021903 hasAuthorship W4226021903A5040457003 @default.
• W4226021903 hasAuthorship W4226021903A5045807220 @default.
• W4226021903 hasAuthorship W4226021903A5046569845 @default.
• W4226021903 hasAuthorship W4226021903A5050155633 @default.
• W4226021903 hasAuthorship W4226021903A5055190032 @default.
• W4226021903 hasAuthorship W4226021903A5068253838 @default.
• W4226021903 hasAuthorship W4226021903A5072200320 @default.
• W4226021903 hasAuthorship W4226021903A5086569880 @default.
• W4226021903 hasAuthorship W4226021903A5088349178 @default.
• W4226021903 hasBestOaLocation W42260219031 @default.
• W4226021903 hasConcept C126322002 @default.
• W4226021903 hasConcept C1862650 @default.
• W4226021903 hasConcept C188816634 @default.
• W4226021903 hasConcept C2779978075 @default.
• W4226021903 hasConcept C71924100 @default.
• W4226021903 hasConcept C72563966 @default.
• W4226021903 hasConceptScore W4226021903C126322002 @default.
• W4226021903 hasConceptScore W4226021903C1862650 @default.
• W4226021903 hasConceptScore W4226021903C188816634 @default.
• W4226021903 hasConceptScore W4226021903C2779978075 @default.
• W4226021903 hasConceptScore W4226021903C71924100 @default.
• W4226021903 hasConceptScore W4226021903C72563966 @default.
• W4226021903 hasFunder F4320321643 @default.
• W4226021903 hasFunder F4320324308 @default.
• W4226021903 hasFunder F4320329498 @default.
• W4226021903 hasIssue "1" @default.
• W4226021903 hasLocation W42260219031 @default.

• next